{"id":40336,"date":"2024-06-19T11:43:57","date_gmt":"2024-06-19T09:43:57","guid":{"rendered":"https:\/\/pgxperts.com\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/"},"modified":"2025-12-18T10:42:54","modified_gmt":"2025-12-18T09:42:54","slug":"escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a","status":"publish","type":"post","link":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/","title":{"rendered":"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento"},"content":{"rendered":"

[et_pb_section fb_built=\u00bb1″ _builder_version=\u00bb4.22.1″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||40px|||\u00bb da_disable_devices=\u00bboff|off|off\u00bb global_colors_info=\u00bb{}\u00bb da_is_popup=\u00bboff\u00bb da_exit_intent=\u00bboff\u00bb da_has_close=\u00bbon\u00bb da_alt_close=\u00bboff\u00bb da_dark_close=\u00bboff\u00bb da_not_modal=\u00bbon\u00bb da_is_singular=\u00bboff\u00bb da_with_loader=\u00bboff\u00bb da_has_shadow=\u00bbon\u00bb][et_pb_row _builder_version=\u00bb4.26.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb0px|auto|10px|auto|false|false\u00bb custom_padding=\u00bb0px||14px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.22.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#878988″ link_font=\u00bb||||on|||#878988|\u00bb link_text_color=\u00bb#878988″ link_font_size=\u00bb14px\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

atr\u00e1s<\/a><\/p>\n

[\/et_pb_text][et_pb_text content_tablet=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF90aXRsZSIsInNldHRpbmdzIjp7ImJlZm9yZSI6IjxoMT4iLCJhZnRlciI6IjwvaDE+IiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@\u00bb content_phone=\u00bb<\/p>\n

Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento<\/h1>\n

\u00bb content_last_edited=\u00bboff|desktop\u00bb _builder_version=\u00bb4.27.0″ _dynamic_attributes=\u00bbcontent\u00bb _module_preset=\u00bbdefault\u00bb text_font=\u00bb–et_global_body_font|700|||||||\u00bb text_text_color=\u00bb#2495D0″ text_font_size=\u00bb44px\u00bb header_font=\u00bb|700|||||||\u00bb header_text_color=\u00bb#2495D0″ header_font_size=\u00bb44px\u00bb custom_margin=\u00bb0px||0px||false|false\u00bb text_font_size_tablet=\u00bb38px\u00bb text_font_size_phone=\u00bb38px\u00bb text_font_size_last_edited=\u00bbon|phone\u00bb header_font_size_tablet=\u00bb38px\u00bb header_font_size_phone=\u00bb38px\u00bb header_font_size_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF90aXRsZSIsInNldHRpbmdzIjp7ImJlZm9yZSI6IjxoMT4iLCJhZnRlciI6IjwvaDE+IiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@[\/et_pb_text][et_pb_text _builder_version=\u00bb4.25.2″ _dynamic_attributes=\u00bbcontent\u00bb _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|0px|0px||false|false\u00bb custom_padding=\u00bb|0px|||false|false\u00bb custom_css_main_element=\u00bbdisplay: inline-block;\u00bb global_colors_info=\u00bb{}\u00bb]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9kYXRlIiwic2V0dGluZ3MiOnsiYmVmb3JlIjoiIiwiYWZ0ZXIiOiIgLyIsImRhdGVfZm9ybWF0IjoiZGVmYXVsdCIsImN1c3RvbV9kYXRlX2Zvcm1hdCI6IiIsImVuYWJsZV9odG1sIjoib2ZmIn19@[\/et_pb_text][et_pb_text _builder_version=\u00bb4.25.2″ _dynamic_attributes=\u00bbcontent\u00bb _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|0px|0px||false|false\u00bb custom_padding=\u00bb|0px||4px|false|false\u00bb custom_css_main_element=\u00bbdisplay: inline-block;\u00bb global_colors_info=\u00bb{}\u00bb]@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9jYXRlZ29yaWVzIiwic2V0dGluZ3MiOnsiYmVmb3JlIjoiICIsImFmdGVyIjoiIiwibGlua190b190ZXJtX3BhZ2UiOiJvZmYiLCJzZXBhcmF0b3IiOiIgfCAiLCJjYXRlZ29yeV90eXBlIjoiY2F0ZWdvcnkiLCJlbmFibGVfaHRtbCI6Im9mZiJ9fQ==@[\/et_pb_text][et_pb_social_media_follow _builder_version=\u00bb4.27.5″ _module_preset=\u00bbdefault\u00bb text_orientation=\u00bbleft\u00bb custom_margin=\u00bb20px||0px|-10px|false|false\u00bb custom_margin_tablet=\u00bb20px||||false|false\u00bb custom_margin_phone=\u00bb0px|||-8px|false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb16px|0px|0px|0px|false|false\u00bb hover_enabled=\u00bb0″ text_orientation_tablet=\u00bbleft\u00bb text_orientation_phone=\u00bbleft\u00bb text_orientation_last_edited=\u00bboff|tablet\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0″][et_pb_social_media_follow_network social_network=\u00bblinkedin\u00bb url=\u00bbhttps:\/\/www.linkedin.com\/company\/pgxperts\/\u00bb icon_color=\u00bb#2495D0″ use_icon_font_size=\u00bbon\u00bb icon_font_size=\u00bb20px\u00bb _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]linkedin[\/et_pb_social_media_follow_network][et_pb_social_media_follow_network social_network=\u00bbxing\u00bb url=\u00bbhttps:\/\/www.xing.com\/pages\/pgxperts-gmbh\u00bb icon_color=\u00bb#2495D0″ use_icon_font_size=\u00bbon\u00bb icon_font_size=\u00bb23px\u00bb _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb background_enable_color=\u00bbon\u00bb global_colors_info=\u00bb{}\u00bb follow_button=\u00bboff\u00bb url_new_window=\u00bbon\u00bb]xing[\/et_pb_social_media_follow_network][\/et_pb_social_media_follow][et_pb_divider color=\u00bb#878988″ _builder_version=\u00bb4.26.0″ _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_divider][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|auto|40px|auto||\u00bb custom_padding=\u00bb0px||0px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb header_2_font=\u00bb|700|||||||\u00bb header_2_text_color=\u00bb#2495D0″ header_2_font_size=\u00bb18px\u00bb custom_margin=\u00bb||5px||false|false\u00bb custom_margin_tablet=\u00bb||5px||false|false\u00bb custom_margin_phone=\u00bb||10px||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb||0px|||\u00bb header_2_font_size_tablet=\u00bb17px\u00bb header_2_font_size_phone=\u00bb16px\u00bb header_2_font_size_last_edited=\u00bbon|phone\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

\n
\n

PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento<\/h2>\n<\/div>\n<\/div>\n

[\/et_pb_text][et_pb_text content_tablet=\u00bb<\/p>\n

\n
\n
\n
\n
\n
F\u00fcrth, 19 junio 2024 \u2013 Tras la escisi\u00f3n de PGXperts GmbH de HMG Systems Engineering GmbH el 01.01.2024, ahora tiene lugar una ampliaci\u00f3n de capital. PGXperts GmbH, con sede en F\u00fcrth, ha completado con \u00e9xito la ronda de financiaci\u00f3n de lanzamiento. El objetivo es la comercializaci\u00f3n del producto a escala internacional y su expansi\u00f3n. <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

\u00bb content_phone=\u00bb<\/p>\n

\n
\n
\n
\n
\n
F\u00fcrth, 19 junio 2024 \u2013 Tras la escisi\u00f3n de PGXperts GmbH de HMG Systems Engineering GmbH el 01.01.2024, ahora tiene lugar una ampliaci\u00f3n de capital. PGXperts GmbH, con sede en F\u00fcrth, ha completado con \u00e9xito la ronda de financiaci\u00f3n de lanzamiento. El objetivo es la comercializaci\u00f3n del producto a escala internacional y su expansi\u00f3n. <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

\u00bb content_last_edited=\u00bbon|phone\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb18px\u00bb text_font_size_tablet=\u00bb17px\u00bb text_font_size_phone=\u00bb16px\u00bb text_font_size_last_edited=\u00bbon|phone\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

\n
\n
\n
\n
\n
F\u00fcrth, 19 junio 2024 \u2013 Tras la escisi\u00f3n de PGXperts GmbH de HMG Systems Engineering GmbH el 01.01.2024, ahora tiene lugar una ampliaci\u00f3n de capital. PGXperts GmbH, con sede en F\u00fcrth, ha completado con \u00e9xito la ronda de financiaci\u00f3n de lanzamiento. El objetivo es la comercializaci\u00f3n del producto a escala internacional y su expansi\u00f3n. <\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n
\n
\n
\n
\n
\n
<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/div>\n<\/section>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2″ _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb min_height=\u00bb361.2px\u00bb custom_margin=\u00bb0px|auto|40px|auto|false|false\u00bb custom_padding=\u00bb0px||0px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.22.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text content_phone=\u00bbLa spin-off PGXperts GmbH es una empresa de software dedicada a la digitalizaci\u00f3n del sector sanitario. Su objetivo es conseguir mejores resultados en los tratamientos para mejorar la calidad de vida de los pacientes. Las soluciones de PGXperts ofrecen un enfoque innovador al permitir a los profesionales sanitarios prescribir medicaci\u00f3n teniendo en cuenta las caracter\u00edsticas individuales de los pacientes y lograr as\u00ed una medicaci\u00f3n personalizada a trav\u00e9s de la farmacogen\u00e9tica.<\/p>\n

El aumento del capital social de PGXperts GmbH permite la expansi\u00f3n internacional del sistema PGXperts. En el marco del proyecto MedeA, PGXperts, junto con Illumina Spain SLU y LIFE BRAIN GmbH, se ha adjudicado el contrato para establecer el genotipado farmacogen\u00e9tico y la interpretaci\u00f3n en la Comunidad Aut\u00f3noma espa\u00f1ola de Extremadura en 2023. Las soluciones de PGXperts tambi\u00e9n se pilotaron con \u00e9xito el a\u00f1o pasado en Alemania, con m\u00e1s de 13 hospitales. <\/span>\u00bb content_last_edited=\u00bboff|desktop\u00bb _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb text_font_size=\u00bb18px\u00bb custom_padding=\u00bb||0px|||\u00bb text_font_size_tablet=\u00bb17px\u00bb text_font_size_phone=\u00bb16px\u00bb text_font_size_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

La spin-off PGXperts GmbH es una empresa de software dedicada a la digitalizaci\u00f3n del sector sanitario. Su objetivo es conseguir mejores resultados en los tratamientos para mejorar la calidad de vida de los pacientes. Las soluciones de PGXperts ofrecen un enfoque innovador al permitir a los profesionales sanitarios prescribir medicaci\u00f3n teniendo en cuenta las caracter\u00edsticas individuales de los pacientes y lograr as\u00ed una medicaci\u00f3n personalizada a trav\u00e9s de la farmacogen\u00e9tica.<\/p>\n

El aumento del capital social de PGXperts GmbH permite la expansi\u00f3n internacional del sistema PGXperts. En el marco del proyecto MedeA, PGXperts, junto con Illumina Spain SLU y LIFE BRAIN GmbH, se ha adjudicado el contrato para establecer el genotipado farmacogen\u00e9tico y la interpretaci\u00f3n en la Comunidad Aut\u00f3noma espa\u00f1ola de Extremadura en 2023. Las soluciones de PGXperts tambi\u00e9n se pilotaron con \u00e9xito el a\u00f1o pasado en Alemania, con m\u00e1s de 13 hospitales. <\/span><\/p>\n

[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_2″ _builder_version=\u00bb4.22.1″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/pgxperts.com\/wp-content\/uploads\/2024\/07\/Thumbnail_Beitragbild_Spin-off_1200x800.jpg\u00bb title_text=\u00bbThumbnail_Beitragbild_Spin-off_1200x800″ force_fullwidth=\u00bbon\u00bb _builder_version=\u00bb4.26.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.0″ _module_preset=\u00bbdefault\u00bb text_font=\u00bbArial||||||||\u00bb text_font_size=\u00bb18px\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n

\u00abEstamos orgullosos de haber completado con \u00e9xito la actual ronda de financiaci\u00f3n en estos tiempos dif\u00edciles. Me gustar\u00eda agradecer a nuestros inversores su confianza y apoyo a nuestro prop\u00f3sito de hacer accesible la medicaci\u00f3n personalizada a todos los pacientes\u00bb. PGXperts est\u00e1 llevando la prescripci\u00f3n de medicamentos a la era de la gen\u00f3mica. Esperamos con confianza la difusi\u00f3n de nuestro innovador sistema PGXperts, haciendo una importante contribuci\u00f3n a la digitalizaci\u00f3n del sistema sanitario \u00bb,<\/em> afirma Herna Mu\u00f1oz-Galeano, fundadora y CEO de PGXperts GmbH. <\/p>\n

[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.26.0″ _module_preset=\u00bbdefault\u00bb custom_margin=\u00bb|auto|40px|auto||\u00bb custom_padding=\u00bb0px||0px|||\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4″ _builder_version=\u00bb4.25.2″ _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_button button_url=\u00bb@ET-DC@eyJkeW5hbWljIjp0cnVlLCJjb250ZW50IjoicG9zdF9saW5rX3VybF9hdHRhY2htZW50Iiwic2V0dGluZ3MiOnsicG9zdF9pZCI6IjQzMTUwIiwiZW5hYmxlX2h0bWwiOiJvZmYifX0=@\u00bb url_new_window=\u00bbon\u00bb button_text=\u00bbPDF Comunicado de prensa\u00bb button_alignment=\u00bbleft\u00bb _builder_version=\u00bb4.27.0″ _dynamic_attributes=\u00bbbutton_url\u00bb _module_preset=\u00bbdefault\u00bb custom_button=\u00bbon\u00bb button_text_color=\u00bb#FFFFFF\u00bb button_bg_color=\u00bb#2495D0″ button_border_width=\u00bb0px\u00bb custom_margin=\u00bb||16px|||\u00bb custom_css_main_element=\u00bbwhite-space: nowrap;||margin:auto;\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"

F\u00fcrth, 19 junio 2024 \u2013 Tras la escisi\u00f3n de PGXperts GmbH de HMG Systems Engineering GmbH el 01.01.2024, ahora tiene lugar una ampliaci\u00f3n de capital. PGXperts GmbH, con sede en F\u00fcrth, ha completado con \u00e9xito la ronda de financiaci\u00f3n de lanzamiento. El objetivo es la comercializaci\u00f3n del producto a escala internacional y su expansi\u00f3n. <\/p>\n","protected":false},"author":10,"featured_media":62979,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[63],"tags":[],"class_list":["post-40336","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pressemitteilung"],"yoast_head":"\nSpin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento - PGXperts<\/title>\n<meta name=\"description\" content=\"PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento\" \/>\n<meta name=\"robots\" content=\"noindex, nofollow\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento - PGXperts\" \/>\n<meta property=\"og:description\" content=\"PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/\" \/>\n<meta property=\"og:site_name\" content=\"PGXperts\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-19T09:43:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-12-18T09:42:54+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"800\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Henrik Schmidt\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hmg_pgxperts\" \/>\n<meta name=\"twitter:site\" content=\"@hmg_pgxperts\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Henrik Schmidt\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/\"},\"author\":{\"name\":\"Henrik Schmidt\",\"@id\":\"https:\/\/pgxperts.com\/es\/#\/schema\/person\/3fa8dc261601c82d7a3dcb223c425a4a\"},\"headline\":\"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento\",\"datePublished\":\"2024-06-19T09:43:57+00:00\",\"dateModified\":\"2025-12-18T09:42:54+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/\"},\"wordCount\":1669,\"publisher\":{\"@id\":\"https:\/\/pgxperts.com\/es\/#organization\"},\"image\":{\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg\",\"articleSection\":[\"Pressemitteilung\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/\",\"url\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/\",\"name\":\"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento - PGXperts\",\"isPartOf\":{\"@id\":\"https:\/\/pgxperts.com\/es\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg\",\"datePublished\":\"2024-06-19T09:43:57+00:00\",\"dateModified\":\"2025-12-18T09:42:54+00:00\",\"description\":\"PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento\",\"breadcrumb\":{\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage\",\"url\":\"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg\",\"contentUrl\":\"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg\",\"width\":1200,\"height\":800,\"caption\":\"PGXperts Enabling-Logo\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\/\/pgxperts.com\/es\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pgxperts.com\/es\/#website\",\"url\":\"https:\/\/pgxperts.com\/es\/\",\"name\":\"PGXperts\",\"description\":\"Individuelle Interaktionsrisiken erkennen\",\"publisher\":{\"@id\":\"https:\/\/pgxperts.com\/es\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pgxperts.com\/es\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/pgxperts.com\/es\/#organization\",\"name\":\"PGXperts\",\"url\":\"https:\/\/pgxperts.com\/es\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/pgxperts.com\/es\/#\/schema\/logo\/image\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"PGXperts\"},\"image\":{\"@id\":\"https:\/\/pgxperts.com\/es\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/x.com\/hmg_pgxperts\",\"https:\/\/de.linkedin.com\/company\/hmg-systems-engineering-gmbh\",\"https:\/\/www.xing.com\/pages\/hmgsystemsengineeringgmbh\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/pgxperts.com\/es\/#\/schema\/person\/3fa8dc261601c82d7a3dcb223c425a4a\",\"name\":\"Henrik Schmidt\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/64dd7a6549fe96db4c7f1ca542c3d2b2302f84395dd5fb2a0e471e2cb4e5bb60?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/64dd7a6549fe96db4c7f1ca542c3d2b2302f84395dd5fb2a0e471e2cb4e5bb60?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/64dd7a6549fe96db4c7f1ca542c3d2b2302f84395dd5fb2a0e471e2cb4e5bb60?s=96&d=mm&r=g\",\"caption\":\"Henrik Schmidt\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento - PGXperts","description":"PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento","robots":{"index":"noindex","follow":"nofollow"},"og_locale":"es_ES","og_type":"article","og_title":"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento - PGXperts","og_description":"PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento","og_url":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/","og_site_name":"PGXperts","article_published_time":"2024-06-19T09:43:57+00:00","article_modified_time":"2025-12-18T09:42:54+00:00","og_image":[{"width":1200,"height":800,"url":"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg","type":"image\/jpeg"}],"author":"Henrik Schmidt","twitter_card":"summary_large_image","twitter_creator":"@hmg_pgxperts","twitter_site":"@hmg_pgxperts","twitter_misc":{"Escrito por":"Henrik Schmidt","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#article","isPartOf":{"@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/"},"author":{"name":"Henrik Schmidt","@id":"https:\/\/pgxperts.com\/es\/#\/schema\/person\/3fa8dc261601c82d7a3dcb223c425a4a"},"headline":"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento","datePublished":"2024-06-19T09:43:57+00:00","dateModified":"2025-12-18T09:42:54+00:00","mainEntityOfPage":{"@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/"},"wordCount":1669,"publisher":{"@id":"https:\/\/pgxperts.com\/es\/#organization"},"image":{"@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage"},"thumbnailUrl":"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg","articleSection":["Pressemitteilung"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/","url":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/","name":"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento - PGXperts","isPartOf":{"@id":"https:\/\/pgxperts.com\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage"},"image":{"@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage"},"thumbnailUrl":"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg","datePublished":"2024-06-19T09:43:57+00:00","dateModified":"2025-12-18T09:42:54+00:00","description":"PGXperts GmbH: La spin-off de farmacogen\u00e9tica de HMG Systems Engineering GmbH, con sede en F\u00fcrth, cierra con \u00e9xito una ronda de financiaci\u00f3n de lanzamiento","breadcrumb":{"@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#primaryimage","url":"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg","contentUrl":"https:\/\/pgxperts.com\/wp-content\/uploads\/2024\/06\/Thumbnail_Beitragbild_Spin-off_1200x800_PA01.jpg","width":1200,"height":800,"caption":"PGXperts Enabling-Logo"},{"@type":"BreadcrumbList","@id":"https:\/\/pgxperts.com\/es\/news\/escision-y-conclusion-de-la-ronda-de-financiacion-de-serie-a\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pgxperts.com\/es\/"},{"@type":"ListItem","position":2,"name":"Spin-off y finalizaci\u00f3n de la financiaci\u00f3n de lanzamiento"}]},{"@type":"WebSite","@id":"https:\/\/pgxperts.com\/es\/#website","url":"https:\/\/pgxperts.com\/es\/","name":"PGXperts","description":"Individuelle Interaktionsrisiken erkennen","publisher":{"@id":"https:\/\/pgxperts.com\/es\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pgxperts.com\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/pgxperts.com\/es\/#organization","name":"PGXperts","url":"https:\/\/pgxperts.com\/es\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/pgxperts.com\/es\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"PGXperts"},"image":{"@id":"https:\/\/pgxperts.com\/es\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hmg_pgxperts","https:\/\/de.linkedin.com\/company\/hmg-systems-engineering-gmbh","https:\/\/www.xing.com\/pages\/hmgsystemsengineeringgmbh"]},{"@type":"Person","@id":"https:\/\/pgxperts.com\/es\/#\/schema\/person\/3fa8dc261601c82d7a3dcb223c425a4a","name":"Henrik Schmidt","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/64dd7a6549fe96db4c7f1ca542c3d2b2302f84395dd5fb2a0e471e2cb4e5bb60?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/64dd7a6549fe96db4c7f1ca542c3d2b2302f84395dd5fb2a0e471e2cb4e5bb60?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/64dd7a6549fe96db4c7f1ca542c3d2b2302f84395dd5fb2a0e471e2cb4e5bb60?s=96&d=mm&r=g","caption":"Henrik Schmidt"}}]}},"_links":{"self":[{"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/posts\/40336","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/users\/10"}],"replies":[{"embeddable":true,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/comments?post=40336"}],"version-history":[{"count":7,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/posts\/40336\/revisions"}],"predecessor-version":[{"id":63650,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/posts\/40336\/revisions\/63650"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/media\/62979"}],"wp:attachment":[{"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/media?parent=40336"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/categories?post=40336"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pgxperts.com\/es\/wp-json\/wp\/v2\/tags?post=40336"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}